Menu

All Posts

HomeAll Posts

Meet the 6 Innovation Spotlight Finalists from this Week’s Fertility Innovation Summit

Events, Fertility, News, Reproductive Health April 20, 2021
Share

Women’s health today is under-served from innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players including investors and insurers. It is imperative to develop the eco-system, shift mindsets and embrace a holistic, women-centered approach. Today’s Fertility Innovation Summit is the second installment of Women’s Health Innovation Summit’s Women’s Health Innovation Series, which runs throughout 2021. Reproductive-health-supporting technologies and research advances…

Bonafide Names Dr. Alyssa Dweck as Chief Medical Officer as the Company Leads the Movement to Provide Hormone-Free Menopause Treatment

Career, Menopause, News April 20, 2021
Share

Bonafide, the company pioneering mainstream medical use of drug-free, naturally derived health solutions for menopause, announces today that Dr. Alyssa Dweck will join its team as its Chief Medical Officer. Bonafide’s products are already trusted by over 9,000 unpaid health care professionals, primarily OBGYNs, and more than 70,000 women.  The addition of Dr. Dweck to Bonafide’s leadership team is in alignment with…

Egg Donor Matching Platform Tulip Closes a $1.7M Seed Round

Fertility, Investment, News, Reproductive Health April 19, 2021
Share

Tulip, the world’s largest egg donor database and trusted resource for intended parents to find their ideal donor, today announced the closing of a $1.7 Million seed round. Launched in November of 2020, Tulip has quickly amassed donors from 90% of the agencies in the U.S – with nearly 20,000 egg donors within its database. The user-friendly, online search platform helps intended…

Renovia Raises a $17M Series C for Its Pelvic Health Focused Digital Therapeutic leva

Investment, News, Pelvic Health, Uncategorized April 19, 2021
Share

Renovia, a women-led company that develops digital therapeutics for female pelvic floor disorders, today announced the closing of an additional round of equity funding totaling $17 million. The financing included new investor, Parian Global Management, along with existing Renovia investors, including Perceptive Life Sciences, Longwood Fund, Ascension Ventures and OSF Ventures. “We’re very pleased to continue working with such an accomplished group of…

Mayne Pharma’s Receives FDA Approval for NEXTSTELLIS, a New Oral Contraceptive Containing E4, the First New Estrogen Introduced in the U.S. in 50 Years

Biotech, News, Reproductive Health April 19, 2021
Share

Mayne Pharma has announced that the U.S. Food and Drug Administration (FDA) has approved NEXTSTELLIS for the prevention of pregnancy. NEXTSTELLIS is the first and only contraceptive pill containing E4, a naturally occurring estrogen, now produced from a plant source, with a unique mechanism of action that offers potential advantages over other estrogens. “When speaking with patients about their contraceptive options, one…

Wildflower Strengthens Commitment to Black Maternal Health with New Tools and Resources for Black Mothers

Access, Maternal Health, News April 19, 2021
Share

Wildflower is announcing a new suite of support for Black mothers and their birthing people, available within the company’s digital platform for navigating healthy pregnancies and growing healthy families as part of the company’s efforts to improve Black maternal health. Healthcare inequity in the U.S. has resulted in a maternal healthcare crisis that disproportionately affects Black women. As an example, Black women…

Coral Partners with DrugViu to Address Minority Representation in Autoimmune Precision Medicine

News April 16, 2021
Share

Coral, a San Francisco biotech developing new clinical tests to improve medication selection and market access for autoimmune patients has partnered with DrugViu, a healthcare technology company that helps patients with autoimmune diseases get full control and consolidate their medical records to find better treatment options, participate in clinical trials and track their contributions to research. Coral Genomics will utilize the DrugViu…

Babyscripts Teams Up With Mississippi Public Health Institute on a New Maternal Health Initiative

Maternal Health, News, Partnership April 16, 2021
Share

Babyscripts, a leading virtual care obstetrics platform, has teamed up with The Mississippi Public Health Institute on an initiative to improve maternal health outcomes and reduce maternal health inequities by offering remote patient monitoring programs to OB-GYN practices to help care for their patients. The initiative will offer eligible Mississippi providers use of the Babyscripts platform, which provides remote patient monitoring to…